Movatterモバイル変換


[0]ホーム

URL:


PL346346A1 - Cyclic prosaposin-derived peptides and uses thereof - Google Patents

Cyclic prosaposin-derived peptides and uses thereof

Info

Publication number
PL346346A1
PL346346A1PL99346346APL34634699APL346346A1PL 346346 A1PL346346 A1PL 346346A1PL 99346346 APL99346346 APL 99346346APL 34634699 APL34634699 APL 34634699APL 346346 A1PL346346 A1PL 346346A1
Authority
PL
Poland
Prior art keywords
derived peptides
prosaposin
cyclic
cyclic prosaposin
peptides
Prior art date
Application number
PL99346346A
Other versions
PL204359B1 (en
Inventor
David E Wright
John S O'brien
Original Assignee
Myelos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Myelos CorpfiledCriticalMyelos Corp
Publication of PL346346A1publicationCriticalpatent/PL346346A1/en
Publication of PL204359B1publicationCriticalpatent/PL204359B1/en

Links

Classifications

Landscapes

PL346346A1998-08-281999-08-20Cyclic prosaposin-derived peptides and uses thereofPL204359B1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US9835998P1998-08-281998-08-28

Publications (2)

Publication NumberPublication Date
PL346346A1true PL346346A1 (en)2002-02-11
PL204359B1 PL204359B1 (en)2010-01-29

Family

ID=22268937

Family Applications (1)

Application NumberTitlePriority DateFiling Date
PL346346APL204359B1 (en)1998-08-281999-08-20Cyclic prosaposin-derived peptides and uses thereof

Country Status (13)

CountryLink
EP (1)EP1105420A1 (en)
JP (2)JP4528443B2 (en)
KR (1)KR20010079695A (en)
CN (1)CN1324367A (en)
AU (1)AU751034B2 (en)
BR (1)BR9913490A (en)
CA (1)CA2341810A1 (en)
CZ (1)CZ2001655A3 (en)
HU (1)HUP0103265A3 (en)
IL (1)IL141586A0 (en)
PL (1)PL204359B1 (en)
WO (1)WO2000012553A1 (en)
ZA (1)ZA200102489B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5571787A (en)1993-07-301996-11-05Myelos CorporationProsaposin as a neurotrophic factor
HUP0103265A3 (en)*1998-08-282002-09-30Myelos Corp San DiegoCyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
AUPQ084899A0 (en)*1999-06-081999-07-01University Of Melbourne, TheNeurotrophin agonists
IL137820A (en)*2000-08-102009-06-15S I S Shulov Inst For SciencePharmaceutical composition for topical administration comprising an analgesic peptide
CN100366286C (en)*2003-04-282008-02-06常州南云科技有限公司 Saposin C-DOPS: A new anticancer drug
CA2650691C (en)2006-04-282015-10-06Children's Hospital Medical CenterFusogenic properties of saposin c and related proteins and peptides for application to transmembrane drug delivery systems
EP2081552A2 (en)*2006-10-202009-07-29Children's Hospital Medical CenterSpontaneously forming ellipsoidal phospholipid unilamellar vesicles
CN103275187B (en)*2013-06-142014-10-29四川合泰新光生物科技有限公司Analgesic peptide FI as well as genes and application thereof
WO2016172409A1 (en)2015-04-232016-10-27The Procter & Gamble CompanyDelivery of surfactant soluble anti-dandruff agent
EP3423031B1 (en)2016-03-032021-09-08The Procter & Gamble CompanyAerosol antidandruff composition
EP3528898A1 (en)2016-10-212019-08-28The Procter and Gamble CompanyConcentrated shampoo dosage of foam designating hair conditioning benefits
US20180110688A1 (en)2016-10-212018-04-26The Procter & Gamble CompanyConcentrated Shampoo Dosage of Foam for Providing Hair Care Benefits
EP3528774A1 (en)2016-10-212019-08-28The Procter and Gamble CompanyConcentrated shampoo dosage of foam designating hair volume benefits
EP3528897A1 (en)2016-10-212019-08-28The Procter & Gamble CompanyDosage of foam for delivering consumer desired dosage volume, surfactant amount, and scalp health agent amount in an optimal formulation space
CN109862944A (en)2016-10-212019-06-07宝洁公司 Foam dosage forms for delivering the dosage form volume and surfactant dosage required by the consumer in an optimal formulation space
US11129783B2 (en)2016-10-212021-09-28The Procter And Gamble PlazaStable compact shampoo products with low viscosity and viscosity reducing agent
US10653590B2 (en)2016-10-212020-05-19The Procter And Gamble CompanyConcentrated shampoo dosage of foam for providing hair care benefits comprising an anionic/zwitterionic surfactant mixture
US11224567B2 (en)2017-06-062022-01-18The Procter And Gamble CompanyHair compositions comprising a cationic polymer/silicone mixture providing improved in-use wet feel
US11679073B2 (en)2017-06-062023-06-20The Procter & Gamble CompanyHair compositions providing improved in-use wet feel
US11141370B2 (en)2017-06-062021-10-12The Procter And Gamble CompanyHair compositions comprising a cationic polymer mixture and providing improved in-use wet feel
MX388495B (en)2017-10-102025-03-20Procter & Gamble COMPACT SHAMPOO COMPOSITION CONTAINING SULFATE-FREE SURFACTANTS.
CN111278418A (en)2017-10-102020-06-12宝洁公司 Compact shampoo composition with amino acid based anionic surfactant and cationic polymer
JP6952906B2 (en)2017-10-102021-10-27ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company How to treat hair or skin with a personal care composition in the form of foam
WO2019074990A1 (en)2017-10-102019-04-18The Procter & Gamble CompanyCompact shampoo composition
WO2019126444A1 (en)2017-12-202019-06-27The Procter & Gamble CompanyClear shampoo composition containing silicone polymers
CN120458929A (en)2018-06-292025-08-12宝洁公司Low surfactant aerosol anti-dandruff compositions
US12226505B2 (en)2018-10-252025-02-18The Procter & Gamble CompanyCompositions having enhanced deposition of surfactant-soluble anti-dandruff agents
US11980679B2 (en)2019-12-062024-05-14The Procter & Gamble CompanySulfate free composition with enhanced deposition of scalp active
CN115151310B (en)2020-02-272024-12-20宝洁公司 Sulfur-containing anti-dandruff compositions with enhanced efficacy and aesthetics
US12427099B2 (en)2020-11-232025-09-30The Procter & Gamble CompanyPersonal care composition
EP4255375B1 (en)2020-12-042025-08-13The Procter & Gamble CompanyHair care composition comprising malodor reduction materials
US11771635B2 (en)2021-05-142023-10-03The Procter & Gamble CompanyShampoo composition
US11986543B2 (en)2021-06-012024-05-21The Procter & Gamble CompanyRinse-off compositions with a surfactant system that is substantially free of sulfate-based surfactants

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
IL106106A0 (en)*1993-06-221993-10-20Interpharm Lab LtdLibrary of polymeric molecules and its preparation
US6271196B1 (en)*1996-03-052001-08-07Regents Of The University Of CaMethods of alleviating neuropathic pain using prosaposin-derived peptides
HUP0103265A3 (en)*1998-08-282002-09-30Myelos Corp San DiegoCyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use

Also Published As

Publication numberPublication date
CN1324367A (en)2001-11-28
ZA200102489B (en)2002-06-04
IL141586A0 (en)2002-03-10
JP2002523518A (en)2002-07-30
EP1105420A1 (en)2001-06-13
KR20010079695A (en)2001-08-22
JP2010150272A (en)2010-07-08
AU751034B2 (en)2002-08-08
JP4528443B2 (en)2010-08-18
HUP0103265A2 (en)2002-02-28
AU5690599A (en)2000-03-21
BR9913490A (en)2001-09-25
WO2000012553A1 (en)2000-03-09
CA2341810A1 (en)2000-03-09
HUP0103265A3 (en)2002-09-30
PL204359B1 (en)2010-01-29
CZ2001655A3 (en)2001-11-14

Similar Documents

PublicationPublication DateTitle
PL346346A1 (en)Cyclic prosaposin-derived peptides and uses thereof
PL348648A1 (en)Cyclic tetrapeptide compound and use thereof
EP1064022A4 (en)Hla-binding peptides and their uses
HUP0102535A3 (en)Cd19xcd3 specific polypeptides and uses thereof
PL344341A1 (en)Peptides
IL128869A0 (en)Pyrozolopyrimidines and pyrazolotriazines
GB9806806D0 (en)Peptides and uses thereof
EP0933422A4 (en)Cyclic lipopeptide acylase
IL131707A0 (en)Acetylcholinesterase-derived peptides and uses thereof
IL125908A0 (en)Peptides and pharmaceutical compositions comprising same
GB9718110D0 (en)Peptides
GB9825854D0 (en)Peptide
EP0970965A4 (en)Cyclic peptides and medicinal use thereof
GB9918155D0 (en)Proteins and peptides
GB9700154D0 (en)Peptides
GB9812675D0 (en)Peptides
EP1080185A4 (en)Myelin basic protein peptides and uses thereof
HUP0000490A3 (en)Cyclic peptide derivatives
IL138477A0 (en)Cyclic aminoguanidines
GB9917165D0 (en)Polypeptides polynuclcotides and uses thereof
GB9807890D0 (en)Peptides
SG74707A1 (en)Cyclic bis-phosphites and compositions
HK1039621A (en)Cyclic prosaposin-derived peptides and uses thereof
EP1132472A4 (en)Novel protein and utilization thereof
EP1067140A4 (en)Novel hemolytic active proteins and genes encoding the same

Legal Events

DateCodeTitleDescription
RECPRectifications of patent specification
VDSOInvalidation of derivated patent or utility model

Ref document number:384787

Country of ref document:PL

Kind code of ref document:A1

LAPSDecisions on the lapse of the protection rights

Effective date:20130820


[8]ページ先頭

©2009-2025 Movatter.jp